Warning (512): /home/pharma/website/current/cakephp/app/pharmalicensing/tmp/cache/ is not writable [CORE/cake/libs/cache/file.php, line 267]
Code
        if ($this->_init && !is_writable($this->settings['path'])) {
            $this->_init = false;
            trigger_error(sprintf(__('%s is not writable', true), $this->settings['path']), E_USER_WARNING);
FileEngine::__active() - CORE/cake/libs/cache/file.php, line 267
FileEngine::init() - CORE/cake/libs/cache/file.php, line 94
Cache::_buildEngine() - CORE/cake/libs/cache.php, line 151
Cache::config() - CORE/cake/libs/cache.php, line 126
include - /home/pharma/website/releases/20120317114903/cakephp/app/pharmalicensing/config/core.php, line 345
Configure::__loadBootstrap() - CORE/cake/libs/configure.php, line 391
Configure::getInstance() - CORE/cake/libs/configure.php, line 52
include - CORE/cake/bootstrap.php, line 38
[main] - /home/pharma/website/releases/20120317114903/cakephp/webroot/pharmalicensing/index.php, line 100

• Home
• Licensing Center
  • Data Center
    • Out-licensing
    • In-licensing
    • Companies
    • Services
  • Reports
  • Newsletter
    • Subscribe
    • Partnering Update
    • Key Reports
    • Pharmalicensing Recommends
  • Pharmalicensing Intelligence
    • Industry News
    • Deals Review
    • Press Releases
    • Articles
  • Profiled Companies
  • Events
• Our Services
  • Partnering Search
  • Company Profiling
  • Reports
  • Pharma Transfer
  • Deal Negotiation
  • Pharmalicensing Intelligence
• About us
  • Case Studies
  • Our Audience
  • FAQ
  • Directions
  • MedicalDeviceLicensing.com
  • Innovaro Corporate
• Contact us

Login    Register

Search

Industry news

• Industry news
• Development
• News

From Oranienburg to the rest of the world: global market launch of Daxas

In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.

Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits Pharmalicensing Intelligence has to offer. Find out more.

Request a demo of
Pharmalicensing Intelligence

Company details

If you want to find out more about the company visit Nycomed profile.

Related reports

Market Research Reports provided by reports.innovaro.com

Nycomed S.C.A. SICAR: PharmaVitae Profile

Mar 2010 - 75 pages - $5,700

Cytotoxic Therapies Market Forecast

Aug 2010 - $15,200

Nycomed S.C.A SICAR: PharmaVitae Profile

Jul 2010 - $200

Nycomed A/S: PharmaVitae Report

Jul 2011 - 78 pages - $5,700

Shop 'X': The global future revenue growth of NFC technology for the retail industry, excluding Europe, 2006-2012 (Databook)

Sep 2007 - 11 pages - $1,295

Nokia starts fight back with launch of Windows Phones

Oct 2011 - 3 pages - $100

Antihormonal Therapies Market Forecast

Jul 2010 - $15,200

Pine Rest Christian Mental Health Services - Strategic SWOT Analysis Review

May 2011 - 15 pages - $125

Testing Services: Outsourced Market Size and Forecasts

Jun 2011 - 5 pages - $3,395

Future Spending of CRM Technologies, Europe, 2006-2012 (Databook)

Jul 2007 - 11 pages - $1,295

More Related Market Research Reports >>>

Related news

Latest News

OXIS International, Inc. (OXIS) Announces the Launch of Oxis Consumer Products Subsidiary

From Oranienburg to the rest of the world: global market launch of Daxas

Straumann launches new CADCAM dental restoration system

Neuronetics selected by World Economic Forum as 2011 Technology Pioneer

QRxPharma to Sponsor Symposium at International Association for the Study of Pain Meetings

Bayer

PharmaNet Joins Medidata Solutions' CRO Partner Program

Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery

Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study

Prometheus Launches the First Serogenetic Test to Predict Risk of Complications from Crohn's Disease

More news... | RSS Feed...

Most Viewed

OXIS International, Inc. (OXIS) Announces the Launch of Oxis Consumer Products Subsidiary

Publication of Phase II trial results of NGR-hTNF in liver cancer by the British Journal of Cancer

Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study

From Oranienburg to the rest of the world: global market launch of Daxas

Straumann launches new CADCAM dental restoration system

Bayer

Neuronetics selected by World Economic Forum as 2011 Technology Pioneer

Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain

Forest Laboratories, Inc. and Gedeon Richter Plc Announce Results from a Phase II Study of Cariprazine for the Treatment of Bipolar Depression

Advanced Life Sciences Sees Funding Opportunity for Restanza in New HHS Medical Countermeasure Report

Therapeutic Target

Cardiovascular

Dermatology

Endocrine and Metabolic

Gastroenterology

Genitourinary

Hematology

Immunology and Allergy

Infection

Musculoskeletal

Neurology

Obstetrics and Gynecology

Oncology

Ophthalmology

Psychiatry

Pulmonary

Categories

Deals and Alliances

Development

Financial Results

Financings

Intellectual Property

Regulatory

Press releases

Deals review

Headlines

PR Newswire

Products:	Partnering Search	Company Profiling	Pharmalicensing Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Industrial Sector	Therapeutic Target	Articles date
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	FAQ	Contact us	Site map

© Copyright 1998-2012 Innovaro Europe Ltd All rights reserved. Terms and Conditions | Contact us